Telmisartan and Amlodipine Tablets 40/5mg

Adult dose

The recommended dose of this medication is 1 tablet once daily, to be taken with water regardless of meals. It is recommended to take it at the same time each day (e.g., morning). In patients with severe renal impairment, therapy should start at a lower dose and be gradually titrated. In patients with liver impairment, the daily dosage must not exceed 40 milligrams. In elderly patients (75 years or older), treatment should begin at a lower dose and be gradually increased.

Child dose

Safety and efficacy in pediatric patients under the age of 18 have not been established; therefore, this medication is not recommended.

This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters; therefore, it should not be used by women who are pregnant or may become pregnant. This medication should not be administered to patients with certain conditions. For example, those who are allergic to this medication, pregnant or breastfeeding women, patients with severe liver disease, aortic stenosis, severe hypotension, cardiogenic shock, or unstable heart failure after acute myocardial infarction. Additionally, patients with primary aldosteronism, heart valve disease, liver impairment, gastrointestinal disorders, renal artery hypertension, dialysis patients, and the elderly should use this medication with caution, particularly when combined with other antihypertensive agents. Common side effects when taking this medication include dizziness and peripheral edema; rare but severe adverse reactions, such as fainting, may occur, so patients should consult healthcare providers immediately if they notice unusual symptoms. During pregnancy, starting or continuing this medication is contraindicated, and it should be discontinued as soon as pregnancy is confirmed. Breastfeeding women should also avoid taking this medication. Since this medication lowers blood pressure, hypotension may occur during the initiation of treatment or when adjusting doses; if hypotension symptoms present, the patient should be placed in a supine position and receive intravenous fluids if necessary. Due to the risk of hyperkalemia, patients with impaired renal function or heart failure should regularly monitor potassium levels in their blood, and caution should be taken when taking potassium supplements or foods high in potassium. Patients with diabetes and cardiovascular disease may have an increased risk of myocardial infarction while using this medication; therefore, appropriate diagnosis and treatment are necessary. This medication may cause drowsiness or dizziness, so caution should be taken when driving or operating hazardous machinery. In the event of an overdose, hypotension, tachycardia, or in severe cases, shock may occur, requiring immediate emergency treatment and careful monitoring of blood pressure and heart function. This medication is not recommended for children, as safety and efficacy have not been sufficiently established. For the elderly, it is safe to start on a low dose and gradually increase the dose.

Serious side effects

• Urticaria
• severe swelling (edema)
• difficulty breathing
• jaundice
• severe allergic reactions
• severe skin reactions
• acute renal failure
• angioedema
• thrombocytopenia
• leukopenia

Mild side effects

• Dizziness
• peripheral edema
• upper respiratory infection
• urinary tract infection
• anemia
• hyperkalemia
• hypoglycemia
• hyponatremia
• hyperglycemia
• depression

This medication is sensitive to light and should be stored in an airtight container protected from light. Additionally, it is important to keep it at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the medication's efficacy and safety.

Appearance

White or off-white rectangular tablet

Package unit

30 tablets (10 tablets/Alu-Alu * 3), 30 tablets/bottle